Flagship Biosciences depends on high quality histology and immunohistochemistry for downstream quantitative pathology services. Through our recent acquisition of IHCtech, we now have in-house immunohistochemistry, immunofluorescence and DNA/RNA ISH capabilities. Over the last ten years, this laboratory optimized over 350 discovery IHC antibodies.
We will develop a protocol in our discovery histology laboratory, and can then transfer this protocol to one of our specialized CLIA laboratory partners. We have close partnerships in place with a large number of histology laboratories, depending on the specific project required. This includes GLP preclinical toxicology focused histology, clinical hematology and hematopathology, speciality laboratories in dermatopathology and gastro-intestinal anatomic pathology.
Please contact us with your specific application to learn more. All of our services are supervised by board-certified MD and DVM pathologists, depending on your requirements.